Omicron vaccine
Showing 8276 - 8300 of 8,312
Antibody Response After Vaccination Trial in Leuven (Combined vaccine against hepatitis A and B (Twinrix))
Unknown status
- Antibody Response After Vaccination
- Combined vaccine against hepatitis A and B (Twinrix)
-
Leuven, BelgiumIDEWE
Dec 13, 2005
HIV Trial in Paris (HIV-1 gp 160, DC-Chol)
Terminated
- HIV Infections
- HIV-1 gp 160
- DC-Chol
-
Paris, FranceHopital Tenon
Nov 10, 2005
Impact of HIV on Measles and Measles Immunisation
Completed
- HIV Infection
- +2 more
- standard-titer measles vaccine
-
Lusaka, ZambiaChawama Clinic
Oct 28, 2005
The Development of Human Papillomavirus Type 16 E7-Specific
Unknown status
- Cervical Cancer
-
Taipei, TaiwanNational Taiwan University Hospital
Dec 19, 2005
Haemophilus Influenzae Type B, Carrier State Trial in Anchorage (Hib conjugate vaccine (HbOC, Wyeth Vaccines))
Completed
- Haemophilus Influenzae Type B
- Carrier State
- Hib conjugate vaccine (HbOC, Wyeth Vaccines)
-
Anchorage, AlaskaCDC Arctic Investigations Program
Sep 8, 2005
Cervical Cancer Trial in Taipei (HPV16 E7 peptide-pulsed autologous DCs)
Unknown status
- Cervical Cancer
- HPV16 E7 peptide-pulsed autologous DCs
-
Taipei, TaiwanNational Taiwan University Hospital
Dec 19, 2005
Mortality, Morbidity Trial in Bissau (Vitamin A)
Completed
- Mortality
- Morbidity
- Vitamin A
-
Bissau, Guinea-BissauBandim Health Project, Apartado 861
Sep 12, 2005
Smallpox Trial in Moenchengladbach (MVA-BN)
Completed
- Smallpox
- MVA-BN
-
Moenchengladbach, GermanyPharmPlanNet Contract Research GmbH
Sep 12, 2005
Hepatitis B, Vaccine Trial in Taipei (Hepatitis B vaccine)
Unknown status
- Hepatitis B
- Vaccine
- Hepatitis B vaccine
-
Taipei, TaiwanNational Taiwan University Hospital
Sep 12, 2005
Prostate Cancer Trial (Immunotherapy allogeneic GM-CSF secreting cellular vaccine)
Completed
- Prostate Cancer
- Immunotherapy allogeneic GM-CSF secreting cellular vaccine
- (no location specified)
Aug 30, 2005
Prostate Cancer Trial (Immunotherapy allogeneic GM-CSF secreting cellular vaccine)
Completed
- Prostate Cancer
- Immunotherapy allogeneic GM-CSF secreting cellular vaccine
- (no location specified)
Aug 30, 2005
HIV Trial in St Louis, Rochester, Nashville (rgp120/HIV-1IIIB, rgp120/HIV-1MN)
Completed
- HIV Infections
- rgp120/HIV-1IIIB
- rgp120/HIV-1MN
-
St Louis, Missouri
- +2 more
Jun 23, 2005
HIV, HIV Seronegativity Trial in Rockville (gp160 MN/LAI-2, ALVAC-HIV MN120TMG (vCP205))
Completed
- HIV Infections
- HIV Seronegativity
- gp160 MN/LAI-2
- ALVAC-HIV MN120TMG (vCP205)
-
Rockville, MarylandWalter Reed Army Institute of Research
Jun 23, 2005
Pertussis Trial (whole-cell pertussis vaccine, diphtheria-tetanus vaccine)
Completed
- Pertussis
- whole-cell pertussis vaccine
- diphtheria-tetanus vaccine
- (no location specified)
Jun 23, 2005
Prevention of Anthrax Infection Trial in United States (rPA102 Vaccine)
Completed
- Prevention of Anthrax Infection
- rPA102 Vaccine
-
Atlanta, Georgia
- +3 more
Jun 23, 2005
Pertussis Trial (diphtheria-tetanus-pertussis vaccine containing whole-cell pertussis, diphtheria-tetanus vaccine)
Completed
- Pertussis
- diphtheria-tetanus-pertussis vaccine containing whole-cell pertussis
- diphtheria-tetanus vaccine
- (no location specified)
Jun 23, 2005
HIV, HIV Seronegativity Trial in Omaha (HIV p24/MF59 Vaccine)
Completed
- HIV Infections
- HIV Seronegativity
- HIV p24/MF59 Vaccine
-
Omaha, NebraskaCreighton Univ Med Ctr / Ped Infect Disease Div
Jun 23, 2005
HIV Trial in Philadelphia (APL 400-003)
Completed
- HIV Infections
- APL 400-003
-
Philadelphia, PennsylvaniaUniv of Pennsylvania Med Ctr
Jun 23, 2005
HIV Trial in St Louis, Rochester (rgp120/HIV-1MN Monovalent Octameric V3 Peptide Vaccine)
Completed
- HIV Infections
- rgp120/HIV-1MN Monovalent Octameric V3 Peptide Vaccine
-
St Louis, Missouri
- +1 more
Jun 23, 2005
HIV, HIV Seronegativity Trial in Philadelphia (APL 400-003)
Completed
- HIV Infections
- HIV Seronegativity
- APL 400-003
-
Philadelphia, PennsylvaniaUniv of Pennsylvania Med Ctr
Jun 23, 2005
HIV Trial in San Francisco (HIV-1 Peptide Vaccine, Microparticulate Monovalent, rgp120/HIV-1MN Monovalent Octameric V3 Peptide
Completed
- HIV Infections
- HIV-1 Peptide Vaccine, Microparticulate Monovalent
- rgp120/HIV-1MN Monovalent Octameric V3 Peptide Vaccine
-
San Francisco, CaliforniaUniv of California at San Francisco Gen Hosp
Jun 23, 2005
HIV Trial in Baltimore, Rochester (HIV-1 Peptide Vaccine, Microparticulate Monovalent)
Completed
- HIV Infections
- HIV-1 Peptide Vaccine, Microparticulate Monovalent
-
Baltimore, Maryland
- +1 more
Jun 23, 2005
HIV, HIV Seronegativity Trial in Worldwide (MN rgp120/HIV-1 and GNE8 rgp120/HIV-1)
Completed
- HIV Infections
- HIV Seronegativity
- MN rgp120/HIV-1 and GNE8 rgp120/HIV-1
-
Birmingham, Alabama
- +66 more
Jun 23, 2005
HIV Trial in Rockville (rgp120/HIV-1IIIB)
Completed
- HIV Infections
- rgp120/HIV-1IIIB
-
Rockville, MarylandWalter Reed Army Institute of Research
Jun 23, 2005
HIV, HIV Seronegativity Trial in Rockville (ALVAC-HIV MN120TMG (vCP205))
Unknown status
- HIV Infections
- HIV Seronegativity
- ALVAC-HIV MN120TMG (vCP205)
-
Rockville, MarylandWalter Reed Army Institute of Research (WRAIR)
Jun 23, 2005